Analyst Expectations for Amylyx Pharma’s Future
Over the past 3 months, 5 analysts have published their opinion on Amylyx Pharma (NASDAQ:AMLX) stock. These analysts…
Why PacWest Bancorp Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
Gainers
PacWest Bancorp (NASDAQ: PACW) rose 29.9% to $12.66 in pre-market trading after multiple insider buys by Officers, Directors reported late Monday.
HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $50 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $50 price target.
Amylyx Pharmaceuticals Q4 EPS $(0.65) Beats $(0.82) Estimate, Sales $21.89
Amylyx Pharmaceuticals (NASDAQ:AMLX) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.82) by 20.73 percent. The company reported quarterly sales of $21.89 million which
HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $50 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $50 price target.
Mixed Signals On Valentine’s Day: How Stocks Are Reacting To January Inflation Data
Inflation cooled slightly in January, but saw increases in some areas due to the impact of surging food, energy and shelter prices on consumers, the U.S Labor Department said Tuesday.
Amylyx Pharmaceuticals Q3 EPS $(0.92) Beats $(0.97) Estimate, Sales $345.00K Beat $80.00K Estimate
Amylyx Pharmaceuticals (NASDAQ:AMLX) reported quarterly losses of $(0.92) per share which beat the analyst consensus estimate of $(0.97) by 5.15 percent. The company reported quarterly sales of $345.00 thousand which
Amylyx Pharmaceuticals Late Thursday Announces Pricing Of ~$214.2M Upsized Public Offering Of 6,693,750 Shares Of Common Stock At A Price Of $32/Share
Amylyx Pharmaceuticals, Inc. ("Amylyx") today announced the pricing of an upsized underwritten public offering of 6,693,750 shares of its common stock at a public offering price of $32.00 per share.
Amylyx Pharmaceuticals Announces Launch Of Public Offering Of 6M Shares Of Common Stock
Amylyx Pharmaceuticals, Inc. ("Amylyx") today announced the launch of an underwritten public offering of 6,000,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S.
Citigroup Maintains Buy on Amylyx Pharma, Raises Price Target to $50
Citigroup analyst Neena Bitritto-Garg maintains Amylyx Pharma (NASDAQ:AMLX) with a Buy and raises the price target from $48 to $50.